Regulatory & Legal

A new investment in a Mid-Atlantic firm highlights how private capital is flowing into the multi-trillion-dollar challenge of fixing the nation's water systems.

How the luxury tourism developer is pioneering data governance to comply with new Saudi laws and power its vision for regenerative tourism.

Dr. Jonathan Gavras, a seasoned executive with deep ties to Healthmap, takes the clinical helm in a strategic move to innovate kidney population health.

With only 1 in 4 Americans having a will, one national law firm is rapidly expanding its services to help families avoid the $2 billion cost of probate.

With a 2027 deadline looming and prices soaring, a junior miner's Nevada project could become vital for America's defense supply chain.

The Virginia-based startup landed a major funding round to automate liquid biopsy sample prep, aiming to make cancer detection faster and more reliable.

A new alliance between XRDNA and the University of Utah is building 'executable systems' that go beyond communication to actively coordinate the physical world.

Nearly 50 workers are on strike at a key WV beverage distributor, protesting a 900% insurance hike and threatening Miller-Coors supplies statewide.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

With a new strategic investor and a star executive on its board, Apreo Health is poised to advance its breakthrough BREATHE Airway Scaffold for severe emphysema.

A new report finds a "U-shaped" recovery where the richest and poorest schools improve, but the middle lags. A pre-pandemic "learning recession" persists.

HireQuest's persistent $105M cash offer for TrueBlue's on-demand arm puts the staffing giant at a crossroads, fueling speculation of a sector shake-up.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

With its first patient enrolled and key EU approvals, Inhibikase pushes its PAH drug IKT-001 forward, balancing clinical hope with financial realities.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

Resideo posted strong Q1 results with an 8% revenue jump to $1.91B, setting a positive stage for the planned separation of its ADI distribution arm.

From over 134,000 applicants, ten nurses are finalists for a $250K prize, shining a light on their work and the challenges facing the global nursing profession.

A new AI-driven ecosystem promises to cut GMP media manufacturing to just 4 weeks, aiming to break a critical bottleneck in cell and gene therapy development.

Groundbreaking research suggests routine X-rays are crucial for young ACL patients to prevent growth issues and reinjury, potentially changing care standards.

Baltimore's Coppin State University reports a historic 23,000 applications, a massive surge that bucks national trends of declining college enrollment.